Theratechnologies (NASDAQ:
THTX) reported quarterly losses of $(0.09) per share which missed the analyst consensus estimate of $(0.02) by 350 percent. This is a 550 percent decrease over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $17.729 million which beat the analyst consensus estimate of $17.547 million by 1.03 percent. This is a 19.48 percent decrease over sales of $22.017 million the same period last year.